Form 4: ACM Research CFO Mark McKechnie Executes Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Mark McKechnie, CFO of ACM Research, exercised stock options and sold 15,000 shares of Class A Common Stock at an average price of $25.22, according to a Form 4 filing.
Summary
- On May 14, 2025, Mark McKechnie, the CFO and Treasurer of ACM Research, exercised stock options to acquire 15,000 shares of Class A Common Stock at a price of $5.60 per share.
- Simultaneously, McKechnie sold 15,000 shares of Class A Common Stock at a weighted average price of $25.22 per share, with individual sales ranging from $25.02 to $25.38.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 7, 2024.
- Following these transactions, McKechnie directly owns 900 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transactions were pre-planned under a 10b5-1 trading plan and do not necessarily reflect a change in the executive's outlook on the company.
Industry Context
Insider transactions are common, and the use of a 10b5-1 plan suggests the sales were pre-planned and not based on current inside information. Investors often monitor these filings for insights into management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a form of long-term incentive.
- Rule 10b5-1 plans are a standard practice for corporate insiders to sell shares while avoiding accusations of insider trading.
- The size of the transaction is relatively small, suggesting it is part of a regular diversification strategy rather than a major shift in investment strategy.
Stakeholder Impact
- The transactions are unlikely to have a significant impact on stakeholders as they were pre-planned and represent a small portion of the company's outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 03/07/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 04/22/2029 | Expiration date of stock options |
| 05/14/2025 | Date of stock option exercise and share sale |
| 05/16/2025 | Date of Form 4 signature |
Keywords
ACM Research, ACMR, Form 4, Mark McKechnie, CFO, Stock Options, Share Sale, Rule 10b5-1, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.